CoChat

Predicting Naltrexone Response in Alcohol‐Dependent Patients: The Contribution of Functional Magnetic Resonance Imaging

Open access
Mann, Karl, Vollstädt‐Klein, Sabine, Reinhard, Iris, Leménager, Tagrid, Fauth‐Bühler, Mira, Hermann, Derik, Hoffmann, Sabine, Zimmermann, Ulrich S., Kiefer, Falk, Heinz, Andreas, Smolka, Michael N. · 2014 · Alcoholism: Clinical and Experimental Research
Cited by 90

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Background: Effect sizes of pharmacotherapy in alcoholism are modest. They might improve if subjects could be divided into more homogeneous subgroups and would then be treated targeted to their neurobiological profile. In such an effort, we tested neural cue reactivity as a potential predictor of treatment response to naltrexone. Alcohol‐associated cues cause brain activations in mesocorticolimbic networks due to the positive reinforcing properties of alcohol. These activations were reported to be associated with relapse behavior. Naltrexone, an antagonist at the mu‐opioid receptor, improves drinking behavior in some but not all patients probably by blocking the positive reinforcement of alcohol. Conversely, acamprosate is proposed to modulate negative reinforcement (withdrawal and cue‐induced withdrawal). Identifying subjects with elevated cue reactivity and testing their response to medical treatment could thus improve our understanding of some of the mechanisms underlying pharmacotherapy response. Methods: A picture‐perception task featuring alcohol‐related and neutral stimuli was presented to 64 recently detoxified alcohol‐dependent patients. Patients came from 1 center of a larger double‐blind randomized multicenter clinical trial (the “PREDICT Study”). They were scanned prior to being randomized to either naltrexone or acamprosate. We examined the interaction between medication and functional magnetic resonance imaging (fMRI) cue reactivity, as measured by the percentage of voxels activated, using the time to the first severe relapse as the outcome criterion. Our a priori formulated hypothesis was that naltrexone but not acamprosate should be efficacious in subjects with high cue reactivity. Results: We observed an interaction effect between pretreatment brain activation induced by alcohol images and medication (acamprosate/naltrexone) on relapse behavior. In line with our hypothesis, this interaction was driven by treatment response to naltrexone in patients with elevated pretreatment cue reactivity in the ventral striatum. Conclusions: fMRI has the potential for predicting treatment response to naltrexone in a subgroup of alcohol‐dependent patients. However, this approach will be limited to researching the mechanisms and principles of treatment response.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/acer.12546

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 90

Metadata

Authors
Mann, K., Vollstädt‐Klein, S., Reinhard, I., Leménager, T., Fauth‐Bühler, M., Hermann, D., Hoffmann, S., Zimmermann, U. S., Kiefer, F., Heinz, A., & Smolka, M. N.
Venue
Alcoholism: Clinical and Experimental Research
Publisher
Wiley
Published
2014-11
Volume
38
Issue
11
Pages
2754-2762
ISSN
  • 0145-6008 (ISSN-L)
  • 1530-0277
OpenAlex
W1980612883
Cited by
90
References
16
FWCI
5.84
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.